ALGIERS- Public pharmaceutical group SAIDAL is negotiating with several suppliers on the purchase of raw material for the manufacture of chloroquine, a drug that has proved its effectiveness against the coronavirus, the CEO of Saidal, Fatouma Akacem, said Saturday in Algiers.
ALGIERS- Minister of Industry and Mining, Ferhat Ait Ali Braham, said Wednesday in Algiers that the Public Group for the Manufacture of Medicines and Pharmaceuticals (Saïdal) has all the technical means and high skills to produce the anti-malarial drug, Chloroquine, used in the treatment of people suffering from covid-19.
ALGIERS- Pharmaceutical group SAIDAL has started, for the first time, manufacturing the hydro-alcoholic gel, a highly requested product in the market, announced the public company.
ALGIERS- The industrial public group "SAIDAL" plans to manufacture and develop the therapeutic protocol, chloroquine, used to treat patients suffering from the coronavirus pandemic (Covid-19), the group marketing and sales director, Youcef Ouakli, told APS on Monday.
BLIDA – The insulin production plant (in the form of a solution for injection in a pre-filled pens), located in the commune of Boufraik (North of Blida (50 km west of Algiers), will be commissioned during the first quarter of 2020, the plant manager announced Monday.
ALGIERS-The Ministry of Industry and Mines has appointed Mohamed Nouas as CEO of Saidal group in replacement of Yacine Tounsi, announced the group.
ALGIERS- Chief Executive Officer of the national pharmaceutical group Saidal Yacine Tounsi stressed Monday, in Algiers, the need to “regulate” investments in the pharmaceutical industry, to meet the needs of the national market and public health.
ALGIERS- The National Pharmaceutical Group Saïdal ambitions to produce 300 million units and achieve a turnover of DZD30 billion by 2019, thanks to the "very ambitious" development plan set up since 2009 by the public authorities, said Monday here CEO Yacine Tounsi.
ALGIERS- The first insulin bottle, produced at the plant of Constantine (431-km east of Algiers) by the national pharmaceutical group SAIDAL in partnership with the Danish firm Novo Nordisk, will be available on the national market by the first half of 2018," announced Monday in Algiers the CEO of SAIDAL, Yacine Tounsi.